Look behind the lecture: real-world evidence in regulatory decision making
In this feature, Jonathan Andrus (Clinical Ink; PA, USA) discusses his presentation from DIA 2019 (23—27 June, CA, USA) concerning the validity of real-world evidence (RWE) and its use in regulatory decision making.
Please sign in or register for FREE
Sign in to The Evidence Base®
Did you know?
Your The Evidence Base™ account also gives you access to communities on regenerative medicine, real-world evidence and drug discovery. Find out more>>